Thermo Fisher Scientific Inc

Historical 13F Holders

Symbol
TMO
CUSIP
883556102
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 883556102 since 12/18/2024, largest first.

Filer % of Class Filed
Vanguard Capital Management LLC 13G 7.5% 4/30/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 367 4.80 M $3.17 B
2026 Q2 2,735 619 M $170 B
2026 Q1 2,714 333 M $165 B
2025 Q4 2,803 378 M $201 B
2025 Q3 2,645 340 M $165 B
2025 Q2 2,584 342 M $138 B
2025 Q1 2,690 340 M $169 B
2024 Q4 2,742 342 M $178 B
2024 Q3 2,697 347 M $213 B
2024 Q2 2,669 358 M $198 B
2024 Q1 2,640 366 M $213 B
2023 Q4 2,616 361 M $192 B
2023 Q3 2,474 343 M $173 B
2023 Q2 2,490 346 M $178 B
2023 Q1 2,484 393 M $197 B
2022 Q4 2,486 363 M $201 B
2022 Q3 2,356 349 M $177 B
2022 Q2 2,370 344 M $187 B
2022 Q1 2,405 348 M $205 B
2021 Q4 2,436 347 M $232 B
2021 Q3 2,228 346 M $198 B
2021 Q2 2,166 345 M $174 B
2021 Q1 2,128 346 M $158 B
2020 Q4 2,120 354 M $168 B
2020 Q3 1,924 353 M $156 B
2020 Q2 1,819 357 M $129 B
2020 Q1 1,748 355 M $101 B
2019 Q4 1,750 364 M $118 B
2019 Q3 1,617 363 M $106 B
2019 Q2 1,636 362 M $106 B
2019 Q1 1,596 359 M $98.1 B
2018 Q4 1,523 361 M $80.7 B
2018 Q3 1,419 364 M $88.8 B
2018 Q2 1,384 357 M $73.9 B
2018 Q1 1,370 356 M $73.4 B
2017 Q4 1,304 356 M $67.6 B
2017 Q3 1,216 351 M $66.4 B
2017 Q2 1,207 339 M $59.1 B
2017 Q1 1,186 349 M $53.7 B
2016 Q4 1,173 349 M $49.4 B
2016 Q3 1,095 351 M $55.8 B
2016 Q2 1,101 350 M $51.6 B
2016 Q1 1,065 362 M $49.3 B
2015 Q4 1,068 359 M $53.6 B
2015 Q3 1,010 360 M $46.3 B
2015 Q2 1,017 354 M $46.0 B
2015 Q1 1,009 358 M $48.1 B
2014 Q4 1,013 367 M $46.1 B
2014 Q3 963 364 M $44.3 B
2014 Q2 954 377 M $44.5 B
2014 Q1 964 362 M $43.6 B